Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells

por Luce, Audrey, Courtin, Aurélie, Levalois, Céline, Altmeyer-Morel, Sandrine, Romeo, Paul-Henri, Chevillard, Sylvie, Lebeau, Jérôme
Publicado 2009

Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib

por Courtin, Aurelie, Smyth, Tomoko, Hearn, Keisha, Saini, Harpreet K, Thompson, Neil T, Lyons, John F, Wallis, Nicola G
Publicado 2016

Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe

por Lebraud, Honorine, Surova, Olga, Courtin, Aurélie, O'Reilly, Marc, Valenzano, Chiara R., Nordlund, Pär, Heightman, Tom D.
Publicado 2018

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

por Courtin, Aurélie, Richards, Frances M., Bapiro, Tashinga E., Bramhall, Jo L., Neesse, Albrecht, Cook, Natalie, Krippendorff, Ben-Fillippo, Tuveson, David A., Jodrell, Duncan I.
Publicado 2013

Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breas...

por Communal, Laudine, Vilasco, Myriam, Hugon-Rodin, Justine, Courtin, Aurélie, Mourra, Najat, Lahlou, Najiba, Le Guillou, Morwenna, de Jotemps, Muriel Perrault, Chauvet, Marie-Pierre, Chaouat, Marc, Pujol, Pascal, Feunteun, Jean, Delaloge, Suzette, Forgez, Patricia, Gompel, Anne
Publicado 2016